(Q43593984)

English

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

liver transplantation

1 reference

based on heuristic

1 reference

based on heuristic

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Surakit Pungpapong

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Bashar A Aqel

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Ludi Koning

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jennifer L Murphy

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tanisha M Henry

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kristen L Ryland

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Maria L Yataco

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Raj Satyanarayana

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Barry G Rosser

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Michael R Charlton

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Andrew P Keaveny

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

3 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

690-700

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

The association between hepatitis C infection and survival after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Response-guided telaprevir combination treatment for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Telaprevir for retreatment of HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data

1 reference

https://api.crossref.org/works/10.1002%2FLT.23669

21 January 2018

Identifiers

10.1002/LT.23669

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43593984&oldid=2101762860"